# Fenretinide in Healthy Young Women at Genetic and Familial Risk

> **NCT01479192** · PHASE3 · TERMINATED · sponsor: **European Institute of Oncology** · enrollment: 20 (actual)

## Conditions studied

- High-Risk Cancer

## Interventions

- **DRUG:** Fenretinide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01479192
- **Lead sponsor:** European Institute of Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-12
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 20 (ACTUAL)
- **Why stopped:** very low rate of patient accrual
- **Last updated:** 2018-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01479192

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01479192, "Fenretinide in Healthy Young Women at Genetic and Familial Risk". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01479192. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*